Opus Genetics, Inc.
Company Stats
- Market Cap
- $402.7M
- as of Sep 30, 2026
- Shares Outstanding
- 83.2M
- Free Float
- 58.6%
Income Statement
- Revenue
- $14.2M
- Operating Income
- -$38.6M
- Net Income
- -$49.6M
- EBITDA
- -$38.5M
- Revenue Growth, 3Y
- -29.1%
Balance Sheet
- Cash & Equivalents
- $45.1M
Returns & Capital
- SBC, 3Y Avg
- $3.4M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $14.2M | — | — |
| FY2024 | $11.0M | — | — |
| FY2023 | $19.0M | — | — |
| FY2022 | $39.9M | — | — |
| FY2021 | $589,000 | — | — |
Annual filing data through FY ended December 31, 2025; shares and float as of October 28, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back